NCT04939623
- Conditions
- Chemically-Induced Disorders, Chronic Pain, Drug Dependence of Morphine Type, +8 more
- Locations
-
- Richmond Road Diagnostic and Treatment Centre Calgary, Alberta, Canada
Clinical trial condition
Substance Withdrawal Syndrome
Explore clinical trials studying Substance Withdrawal Syndrome. Study availability and eligibility vary by location and protocol.
60 public trials
5 recruiting studies
Substance Withdrawal Syndrome trial results
NCT05834478
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +6 more
- Locations
-
- Emory University Clinical Research Network Atlanta, Georgia, United States
- Health Sciences Research Building Atlanta, Georgia, United States
- Rollins School of Public Health Atlanta, Georgia, United States
- 12 Executive Park Drive Atlanta, Georgia, United States
Recruiting
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
NCT06675539
- Conditions
- Addiction, Substance, Alcohol Dependence, Alcohol Use Disorder, +7 more
- Locations
-
- Etablissement Public de Santé Barthélemy Durand Étampes, France
NCT05883358
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +2 more
- Locations
-
- Salem Anaesthesia Pain Clinic Surrey, British Columbia, Canada
Recruiting
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
NCT05461820
- Conditions
- Autoimmune Diseases, Chemically-Induced Disorders, Disease Attributes, +18 more
- Locations
-
- the First Affiliated Hospital of Nanjing Medical University Nanjing, China
Not yet recruiting
Dexmedetomidine for Invasive Ventilation In the NEOnate
NCT07493785
- Conditions
- Agnosia, Chemically-Induced Disorders, Infant Discomfort, +14 more
- Locations
-
- CHU Brest - Hôpital Morvan Brest, France
- Centre Hospitalier Intercommunal de Créteil Créteil, France
- CHU Grenoble Alpes Grenoble, France
- CHRU Lille Lille, France
Active, not recruiting
Neurostimulation to Improve NOWS Outcomes
NCT05129020
- Conditions
- Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
- Locations
-
- Medical University of South Carolina - Shawn Jenkins Children's Hospital Charleston, South Carolina, United States
- UT Southwestern Medical Center / Parkland Memorial Hospital Dallas, Texas, United States
- University of Texas Health Science Center San Antonio San Antonio, Texas, United States
Active, not recruiting
Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia
NCT04147533
- Conditions
- Bone Marrow Diseases, Chemically-Induced Disorders, Chronic Disease, +17 more
- Locations
-
- University Hospital Brno Brno, Czechia
- University Hospital Hradec Kralove Hradec Králové, Czechia
- University Hospital Olomouc Olomouc, Czechia
- University Hospital Ostrava Ostrava, Czechia
Completed
Efficacy of XYZ for Withdrawal Syndrome
NCT07543809
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +1 more
- Locations
-
- Chongqing Jiangbei Hospital of Traditional Chinese Medicine Chongqing, Chongqing Municipality, China
NCT05053503
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- Hazelden Betty Ford Foundation Rancho Mirage, California, United States
- Gaudenzia, Inc. Crownsville, Maryland, United States
- Hazelden Betty Ford Foundation Center City, Minnesota, United States
- Hazelden Betty Ford Foundation Plymouth, Minnesota, United States